Detall de la convocatòria
Característiques
Característica |
---|
Objectiu de la convocatòria
The mission of The New York Stem Cell Foundation is to accelerate cures for the major diseases of our time through stem cell research. |
Característiques principals
NYSCF is soliciting applications from early career investigators for Innovator awards to be used for exploring the basic biology and translational potential of stem cells. The goal of this initiative is to foster bold and innovative science with the potential to transform the field of stem cell research, and advance understanding and use of stem cells for the treatment of human disease. In addition to providing funding, NYSCF would partner with the investigator to advance translational goals of the research. |
Lloc de presentació
El personal de l'IMIM i PSMAR que necessiteu més informació adreceu-vos a: Servei de Recerca. C/ Doctor Aiguader, 88. 08003-Barcelona. Tel.: 93.316.04.00. Carol Barnwell: cbarnwell@imim.es Ext.: 1670 Marta López: mlopez4@imim.es Ext.: 1576 |
Convocatòria (URL)
Call: http://www.nyscf.org/grants/stem-cell-investigator-awards FAQs: http://www.nyscf.org/grants/investigator-program-faq |
Requisits
To be eligible, candidates must: In addition, since routes to independence vary significantly outside of the United States, candidates based at institutions outside the United States should consider the following when assessing their eligibility: If the answer to any of these questions is yes, and the candidate has also met the other eligibility criteria, he/she may be eligible to apply. |
Dotació
Up to $300,000 USD per annum |
Durada
Up to five years. |
Documentació
All applications must be submitted through NYSCF’s online grant management system. To create an account and submit your application, please visit: http://www.nyscf.org/applyinvestigator The application components include: All applications must provide assurance of compliance with local research regulatory bodies and with local laws in advance of the award start date. Additionally, for applications using human embryonic stem cells, human tissue, or human trials, the candidate must obtain appropriate Embryonic Stem Cell Research Oversight Committee (ESCRO) and human subjects research approvals in advance of the award start date. |
Arxius
Arxiu |
---|